Business Description
OmniAb is a California-based biotechnology company that licenses its antibody discovery technology to drug developers and research institutions across the United States, Europe, Asia, and Canada. The company has developed a suite of genetically engineered animals ? including modified rats, mice, chickens, and cattle ? whose immune systems produce antibodies with human-compatible sequences, making them well-suited for therapeutic drug development. OmniAb also offers AI-driven tools to further refine and optimize antibody candidates identified through its platform.
